IHH Healthcare

Broker's Calls

'Better quarters ahead' for IHH Healthcare: CGS-CIMB

CGS-CIMB analyst Ngoh Yi Sin has maintained her “add” rating on IHH Healthcare, but with a lower target price of RM6.10 ($2.00) and lower earnings per share (EPS) forecast. 


IHH looks beyond Covid; analysts see turnaround in 2HFY2020

Since the start of the year, IHH Healthcare’s share price has fallen some 6% while ParkwayLife REIT (PLife REIT), in which IHH has a 35.7% stake, is up almost 8% this year.

Broker's Calls

IHH, Raffles Medical likely to be hit by fall in medical tourists: CGS-CIMB

SINGAPORE (June 12): Given the hit to medical tourism due to measures to curb the spread of Covid-19, hospital operators are likely to be more severely impacted in 2Q, according to CGS-CIMB Researc


Healthcare and glove stocks march on as Wuhan virus continues spread, claims higher deaths

SINGAPORE (Jan 28): Glove manufacturers and healthcare stocks listed on the Singapore Exchange continued their ascent today as the spread of the coronavirus originating from Wuhan included more cou


Ageing trend supports spending, but earnings of stocks dip on costs

SINGAPORE (Dec 20): Eight in 10 medical practitioners say Singapore’s healthcare system should focus more on disease prevention as Singaporeans live longer and are more likely to contract a chronic


IHH Healthcare reverses out of the red with 3Q earnings of $77.3 mil

SINGAPORE (Nov 29): IHH Healthcare posted earnings of RM236.3 million ($77.3 million) for 3QFY2019 ended September, reversing from losses of RM104.1 million a year ago.

Trans-boundary haze

Hazy skies have little impact on healthcare providers, says CGS-CIMB

SINGAPORE (Sept 25): The ongoing haze has little impact on healthcare providers in terms of revenue or share price, but prolonged haze conditions showed an increase in admissions to private hospita


IHH Healthcare to acquire private hospital in Malaysia for $336 mil

SINGAPORE (Sept 17): IHH Healthcare is seeking to strengthen its position in Malaysia with the proposed acquisition of entire issued share capital of Prince Court Medical Centre for RM 1.02 billion

Broker's Calls

China could give healthcare players a shot in the arm, says CGS-CIMB

SINGAPORE (June 11): CGS-CIMB Research says China could be the “cure” for anaemic local growth among Singapore-listed healthcare providers, with a total healthcare market size that is some 46 times

Broker's Calls

IHH Healthcare to see an exciting 2019 with increasingly palatable valuations: UOB

SINGAPORE (May 31): UOB Kay Hian is maintaining “buy” on IHH Healthcare with a target price of RM6.30 ($2.07), which implies 32.8 times 2020F P/E – well below its historical five-year 12 month forw

Be informed of the stories that matter